Similar Posts
Celcuity CEO Details Gedatolisib NDA, July PDUFA and Launch Plans at TD Cowen Conference
Celcuity (NASDAQ:CELC) CEO and co-founder Brian Sullivan outlined the company’s clinical programs, regulatory progress, and commercial launch preparations for gedatolisib during a fireside chat at TD Cowen’s 46th Annual Healthcare Conference. Sullivan described Celcuity as a clinical-stage oncology Source link
Global macro hedge funds and institutions fuel stock market demand
Global macro hedge funds and institutions fuel stock market demand Source link
Tuesday Recap, 4 Potential Trades – Blue Horseshoe Stocks
Tuesday’s Runners: We were able to get things back on track for Tuesday’s premarket report. after Monday’s results were less than outstanding. We offered up a slate of four possible options targets and met with some pretty good results. Things should begin to get much more interesting today, with a good set of earnings reporters on…
STOCK TIPS FOR SEP 18 2024
STOCK (FUTURE / CASH / OPTION ) NIFTY (FUTURE / OPTION) BANK NIFTY (FUTURE / OPTION) FUTURE STOCK TIPS: XXXX (SEP. FUT.) BUY ABOVE XX TGT XXXX S/L XX AND SELL BELOW XXX TGT XXXX S/L XX XXXX (SEP. FUT.) BUY ABOVE…
Friday File: Pangea’s Wizard for Gold Riches?
Gold is hitting all-time highs again this week, so we’re going to focus on something a little new and different in the gold market for your Friday File. That doesn’t mean we should all be loading up on gold right now, of course, there’s always risk in buying what is most popular… but I’ve allocated…
Friday’s Major Movers, Fresh Ideas to Start the Week – Blue Horseshoe Stocks
Add Another Week to the Streak: The pendulum swung back to the bullish side of things for the markets on Friday, which meshed well with our exclusively bullish slate of potential options plays in our premarket report for the day. We had loaded up with four possible targets, and all four were good ideas. That stretched our…